Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 24.28% vs 7.42% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 43.32% vs -13.97% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -11.83% vs 6.17% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 33.33% vs -25.00% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Shijiazhuang Yiling Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 24.28% vs 7.42% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 3.46% vs -6.52% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 43.32% vs -13.97% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 26.03% vs 7.39% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -11.83% vs 6.17% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -10.13% vs 6.13% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 33.33% vs -25.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 300.00% vs -98.96% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






